Femasys is simultaneously conducting the FINALE pivotal trial for U.S. FDA approval, with enrollment ongoing. The company also develops fertility …
Femasys Secures First European Order for Non-Surgical Contraceptive FemBloc
Categories:
Related Post
The 3rd NCFP: Demographic dividend and climate change in focus | The Manila TimesThe 3rd NCFP: Demographic dividend and climate change in focus | The Manila Times
(The total fertility rate of the Philippines dropped from 4.1 to 1.9 in 2022, while the country’s 2022 labor force population, ages 15 to 64, is 61.4 …
Home Pregnancy Test Company Wins Dismissal of Pixel Wiretapping Suit – Inside PrivacyHome Pregnancy Test Company Wins Dismissal of Pixel Wiretapping Suit – Inside Privacy
… fertility test kits. Saedi v. SPD Swiss Precision Diagnostics d/b/a Clearblue, 2025 WL 1141168 (C.D. Cal. Feb. 27, 2025). The plaintiff, Roz Saedi …
Celebrating World IVF Day: Innovations and Breakthroughs in Fertility – Times of IndiaCelebrating World IVF Day: Innovations and Breakthroughs in Fertility – Times of India
The World IVF Day celebrates the pioneering advancements in assisted reproductive technology (ART) that have revolutionized the field of fertility …